Skip to content
  • Home
  • About
  • Contact
  • Services
  • Advertise with Us
US Pharma Marketing Logo

US Pharma Marketing

  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A

Author: Jayshree Gondane

Jayshree Gondane, BHMS student and healthcare enthusiast with a genuine interest in medical sciences, patient well-being, and the real-world workings of the healthcare system.
Why Pharma Needs a Patient-Centric Sales Model
Posted in
  • Strategy & Execution

Why Pharma Needs a Patient-Centric Sales Model

For decades, pharmaceutical sales strategies focused primarily on physicians. Sales representatives built relationships with doctors, presented … Why Pharma Needs a Patient-Centric Sales ModelRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
How Clinical Trial Delays Affect Investor Confidence
Posted in
  • Industry Landscape

How Clinical Trial Delays Affect Investor Confidence

Clinical trials represent the most critical and expensive stage in pharmaceutical development. Before a new therapy … How Clinical Trial Delays Affect Investor ConfidenceRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
Why Physician Education Drives Faster Drug Adoption
Posted in
  • Strategy & Execution

Why Physician Education Drives Faster Drug Adoption

The success of a new pharmaceutical product does not depend solely on regulatory approval or clinical … Why Physician Education Drives Faster Drug AdoptionRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
How Storytelling Improves Pharma Marketing Outcomes
Posted in
  • Uncategorized
  • Your POV

How Storytelling Improves Pharma Marketing Outcomes

1. Storytelling Humanizes Complex Scientific Information Pharmaceutical products are developed through highly technical processes involving molecular … How Storytelling Improves Pharma Marketing OutcomesRead more

by Jayshree Gondane•March 5, 2026March 5, 2026•0
Why Life Sciences Companies Struggle With Digital Adoption
Posted in
  • Digital Transformation

Why Life Sciences Companies Struggle With Digital Adoption

Digital transformation has reshaped industries ranging from banking to retail, yet life sciences companies -including pharmaceutical, … Why Life Sciences Companies Struggle With Digital AdoptionRead more

by Jayshree Gondane•March 4, 2026March 4, 2026•0
How Poor Forecasting Impacts U.S. Drug Commercialization
Posted in
  • Strategy & Execution

How Poor Forecasting Impacts U.S. Drug Commercialization

U.S. prescription drug spending reached nearly $722 billion in 2023, according to CMS data available at https://data.cms.gov. … How Poor Forecasting Impacts U.S. Drug CommercializationRead more

by Jayshree Gondane•March 4, 2026March 4, 2026•0
Why Many Pharma Launches Miss Revenue Targets in the U.S. Market
Posted in
  • Case Studies & Trends
  • Strategy & Execution

Why Many Pharma Launches Miss Revenue Targets in the U.S. Market

Roughly half of new drug launches in the United States fail to meet first-year revenue expectations. … Why Many Pharma Launches Miss Revenue Targets in the U.S. MarketRead more

by Jayshree Gondane•March 1, 2026March 1, 2026•0
How Omnichannel Marketing Is Reshaping U.S. Pharma Sales Strategy
Posted in
  • Digital Transformation

How Omnichannel Marketing Is Reshaping U.S. Pharma Sales Strategy

In the United States, pharmaceutical sales used to revolve around one primary engine: the field representative. … How Omnichannel Marketing Is Reshaping U.S. Pharma Sales StrategyRead more

by Jayshree Gondane•March 1, 2026March 1, 2026•0
Why Scientific Messaging Fails to Connect With Physicians
Posted in
  • Industry Landscape
  • Your POV

Why Scientific Messaging Fails to Connect With Physicians

The U.S. pharmaceutical industry operates at the highest standard of scientific rigor in the world. Drug … Why Scientific Messaging Fails to Connect With PhysiciansRead more

by Jayshree Gondane•March 1, 2026March 1, 2026•0
How Compliance Fears Limit Effective Pharma Marketing in the U.S. Pharmaceutical Industry
Posted in
  • Regulatory Compliance

How Compliance Fears Limit Effective Pharma Marketing in the U.S. Pharmaceutical Industry

In the United States, pharmaceutical marketing operates under some of the strictest regulatory scrutiny in the … How Compliance Fears Limit Effective Pharma Marketing in the U.S. Pharmaceutical IndustryRead more

by Jayshree Gondane•February 28, 2026February 28, 2026•0

Posts pagination

Previous 1 … 4 5 6 … 20 Next

Recent Posts

  • The Silent Architects: How Private Equity Is Rewriting the Rules of Pharmaceutical Commercialization
  • Location Is the New Targeting: How Geofencing Is Changing Who Gets Diagnosed and Treated
  • When a Drug Loses Its Patent, Marketing Becomes Defense, Not Growth
  • The Hidden Compliance Risk of AI in Pharmaceutical Promotion
  • The Truth About Drug Price Transparency Laws and Pharmaceutical Marketing Strategy

Recent Comments

No comments to show.
Copyright © 2026 US Pharma Marketing.
Powered by WordPress and HybridMag.
  • Industry Landscape
  • Your POV
  • Sponsored
  • Case Studies & Trends
  • Job & Career
  • Strategy & Execution
  • Digital Transformation
  • Regulatory Compliance
  • Leader Q&A